Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Sunday. The firm issued a hold rating on the stock.

Retractable Technologies Stock Up 3.8 %

Shares of RVP stock opened at $0.75 on Friday. Retractable Technologies has a 1 year low of $0.70 and a 1 year high of $1.34. The stock has a market cap of $22.54 million, a PE ratio of -1.23 and a beta of 2.06. The business’s fifty day moving average is $0.80 and its 200-day moving average is $0.98. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51.

Retractable Technologies (NYSE:RVP) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%. The firm had revenue of $6.03 million for the quarter.

Insider Activity

In related news, CEO Thomas J. Shaw acquired 71,422 shares of Retractable Technologies stock in a transaction dated Friday, September 20th. The stock was acquired at an average cost of $0.82 per share, with a total value of $58,566.04. Following the purchase, the chief executive officer now directly owns 14,743,907 shares in the company, valued at $12,090,003.74. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In the last ninety days, insiders have bought 176,179 shares of company stock worth $144,814. 54.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC purchased a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent quarter. Institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.